Phaxiam-Therapeutics on Bioeconhttps://en.bioecon.ru/companies/phaxiam-therapeutics/Recent content in Phaxiam-Therapeutics on BioeconHugoen-USSat, 08 Aug 2026 23:18:12 +0700Bacteriophage therapyhttps://en.bioecon.ru/technology/bacteriophage-therapy/Sat, 08 Aug 2026 00:00:00 +0000https://en.bioecon.ru/technology/bacteriophage-therapy/Naturally occurring or precision-engineered bacterial viruses that selectively lyse a target pathogen without disrupting the rest of the microbiome — a genuine answer to antimicrobial resistance still working through the clinical-trial design problems that have already bankrupted one European pioneer.